Copper oxide nanoparticles inhibit the metabolic activity of Saccharomyces cerevisiae.

about

Copper Oxide Nanoparticles Impact Several Toxicological Endpoints and Cause Neurodegeneration in Caenorhabditis elegans.Can CuO nanoparticles lead to epigenetic regulation of antioxidant enzyme system?

P2860

Q36212000-A9976492-2C53-4A62-8E02-8C147D9E5C39 Q38968426-2C9C9202-5A08-4C0F-AE36-1AFC94E9B50B

P2860

Copper oxide nanoparticles inhibit the metabolic activity of Saccharomyces cerevisiae.

Item

http://www.wikidata.org/entity/Q53182103

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Copper oxide nanoparticles inhibit the metabolic activity of Saccharomyces cerevisiae.

@en

Copper oxide nanoparticles inhibit the metabolic activity of Saccharomyces cerevisiae.

@nl

type

Item

label

Copper oxide nanoparticles inhibit the metabolic activity of Saccharomyces cerevisiae.

@en

Copper oxide nanoparticles inhibit the metabolic activity of Saccharomyces cerevisiae.

@nl

prefLabel

Copper oxide nanoparticles inhibit the metabolic activity of Saccharomyces cerevisiae.

@en

Copper oxide nanoparticles inhibit the metabolic activity of Saccharomyces cerevisiae.

@nl

P1476

Copper oxide nanoparticles inhibit the metabolic activity of Saccharomyces cerevisiae.

@en

P2093

Anthony D Kappell

http://www.w3.org/2001/XMLSchema#string

Krassimira R Hristova

http://www.w3.org/2001/XMLSchema#string

Michael J Mashock

http://www.w3.org/2001/XMLSchema#string

Nadia Hallaj

http://www.w3.org/2001/XMLSchema#string

P2860

Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles

Silver nanoparticle protein corona composition in cell culture media

Size-dependent toxicity of metal oxide particles—A comparison between nano- and micrometer size

Toxicity of copper oxide nanoparticle suspensions to aquatic biota.

Research strategies for safety evaluation of nanomaterials, part V: role of dissolution in biological fate and effects of nanoscale particles.

Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).

Biogenic nanoparticles: copper, copper oxides, copper sulphides, complex copper nanostructures and their applications.

Cell membrane damage and protein interaction induced by copper containing nanoparticles--importance of the metal release process.

In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility.

Toxicity of CuO nanoparticles to yeast Saccharomyces cerevisiae BY4741 wild-type and its nine isogenic single-gene deletion mutants.

P304

134-143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ETC.3159

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26178758

http://www.w3.org/2001/XMLSchema#string

P921

nanoparticle

Saccharomyces cerevisiae

Copper oxide nanoparticles inhibit the metabolic activity of Saccharomyces cerevisiae.

about

P2860

P2860

Copper oxide nanoparticles inhibit the metabolic activity of Saccharomyces cerevisiae.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921